91制片厂

Published on Market Research Reports庐 Inc. ()

Home > Global Valsartan API Market Research Report 2023

Global Valsartan API Market Research Report 2023

Publication ID: 
PB504246546
Publication Date: 
May 22, 2023
Pages: 
120
Publisher: 
MRRPB5
Countries: 
Global [1]
USD 2,900.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Specialty Chemicals [2]
Manufacturing (Chemicals) [3]
Chemicals [4]
Description: 

Valsartan(CAS锛�137862-53-4) is a medication used to treat high blood pressure, heart failure, and diabetic kidney disease.
The global Valsartan API market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Valsartan API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Valsartan API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Valsartan API include Biophore India Pharmaceuticals Pvt Ltd, Dr. Reddy's Laboratories, NEWEDGE Overseas, Suanfarma, Summit Pharmaceuticals Europe Srl, Octavius Pharma Pvt. Ltd, Synaptics Labs, Ami Lifesciences Private Limited and Zhuhai Rundu Pharmaceutical Co.,Ltd, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Valsartan API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Valsartan API.
The Valsartan API market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Valsartan API market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Valsartan API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Biophore India Pharmaceuticals Pvt Ltd
Dr. Reddy's Laboratories
NEWEDGE Overseas
Suanfarma
Summit Pharmaceuticals Europe Srl
Octavius Pharma Pvt. Ltd
Synaptics Labs
Ami Lifesciences Private Limited
Zhuhai Rundu Pharmaceutical Co.,Ltd
Zhejiang Tianyu Pharmaceutical
Menovo Pharmaceutical Co Ltd
Sun Pharma
Mylan
Cadila Pharmaceuticals
Mankind Pharma
Zhejiang Huahai Pharmaceutical
Ipca Laboratories
Zhejiang Hisun Pharmaceutical
DEAFARMA
CHEMO
Laurus Labs
Segment by Type
Above 98 %
Above 99 %
Segment by Application
Tablets
Capsules
Others
Production by Region
North America
Europe
China
India
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Valsartan API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Valsartan API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Valsartan API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Valsartan API Market Overview
1.1 Product Definition
1.2 Valsartan API Segment by Type
1.2.1 Global Valsartan API Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Above 98 %
1.2.3 Above 99 %
1.3 Valsartan API Segment by Application
1.3.1 Global Valsartan API Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Valsartan API Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Valsartan API Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Valsartan API Production Estimates and Forecasts (2018-2029)
1.4.4 Global Valsartan API Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Valsartan API Production Market Share by Manufacturers (2018-2023)
2.2 Global Valsartan API Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Valsartan API, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Valsartan API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Valsartan API Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Valsartan API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Valsartan API, Product Offered and Application
2.8 Global Key Manufacturers of Valsartan API, Date of Enter into This Industry
2.9 Valsartan API Market Competitive Situation and Trends
2.9.1 Valsartan API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Valsartan API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Valsartan API Production by Region
3.1 Global Valsartan API Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Valsartan API Production Value by Region (2018-2029)
3.2.1 Global Valsartan API Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Valsartan API by Region (2024-2029)
3.3 Global Valsartan API Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Valsartan API Production by Region (2018-2029)
3.4.1 Global Valsartan API Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Valsartan API by Region (2024-2029)
3.5 Global Valsartan API Market Price Analysis by Region (2018-2023)
3.6 Global Valsartan API Production and Value, Year-over-Year Growth
3.6.1 North America Valsartan API Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Valsartan API Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Valsartan API Production Value Estimates and Forecasts (2018-2029)
3.6.4 India Valsartan API Production Value Estimates and Forecasts (2018-2029)
4 Valsartan API Consumption by Region
4.1 Global Valsartan API Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Valsartan API Consumption by Region (2018-2029)
4.2.1 Global Valsartan API Consumption by Region (2018-2023)
4.2.2 Global Valsartan API Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Valsartan API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Valsartan API Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Valsartan API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Valsartan API Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Valsartan API Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Valsartan API Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Valsartan API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Valsartan API Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Valsartan API Production by Type (2018-2029)
5.1.1 Global Valsartan API Production by Type (2018-2023)
5.1.2 Global Valsartan API Production by Type (2024-2029)
5.1.3 Global Valsartan API Production Market Share by Type (2018-2029)
5.2 Global Valsartan API Production Value by Type (2018-2029)
5.2.1 Global Valsartan API Production Value by Type (2018-2023)
5.2.2 Global Valsartan API Production Value by Type (2024-2029)
5.2.3 Global Valsartan API Production Value Market Share by Type (2018-2029)
5.3 Global Valsartan API Price by Type (2018-2029)
6 Segment by Application
6.1 Global Valsartan API Production by Application (2018-2029)
6.1.1 Global Valsartan API Production by Application (2018-2023)
6.1.2 Global Valsartan API Production by Application (2024-2029)
6.1.3 Global Valsartan API Production Market Share by Application (2018-2029)
6.2 Global Valsartan API Production Value by Application (2018-2029)
6.2.1 Global Valsartan API Production Value by Application (2018-2023)
6.2.2 Global Valsartan API Production Value by Application (2024-2029)
6.2.3 Global Valsartan API Production Value Market Share by Application (2018-2029)
6.3 Global Valsartan API Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Biophore India Pharmaceuticals Pvt Ltd
7.1.1 Biophore India Pharmaceuticals Pvt Ltd Valsartan API Corporation Information
7.1.2 Biophore India Pharmaceuticals Pvt Ltd Valsartan API Product Portfolio
7.1.3 Biophore India Pharmaceuticals Pvt Ltd Valsartan API Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Biophore India Pharmaceuticals Pvt Ltd Main Business and Markets Served
7.1.5 Biophore India Pharmaceuticals Pvt Ltd Recent Developments/Updates
7.2 Dr. Reddy's Laboratories
7.2.1 Dr. Reddy's Laboratories Valsartan API Corporation Information
7.2.2 Dr. Reddy's Laboratories Valsartan API Product Portfolio
7.2.3 Dr. Reddy's Laboratories Valsartan API Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Dr. Reddy's Laboratories Main Business and Markets Served
7.2.5 Dr. Reddy's Laboratories Recent Developments/Updates
7.3 NEWEDGE Overseas
7.3.1 NEWEDGE Overseas Valsartan API Corporation Information
7.3.2 NEWEDGE Overseas Valsartan API Product Portfolio
7.3.3 NEWEDGE Overseas Valsartan API Production, Value, Price and Gross Margin (2018-2023)
7.3.4 NEWEDGE Overseas Main Business and Markets Served
7.3.5 NEWEDGE Overseas Recent Developments/Updates
7.4 Suanfarma
7.4.1 Suanfarma Valsartan API Corporation Information
7.4.2 Suanfarma Valsartan API Product Portfolio
7.4.3 Suanfarma Valsartan API Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Suanfarma Main Business and Markets Served
7.4.5 Suanfarma Recent Developments/Updates
7.5 Summit Pharmaceuticals Europe Srl
7.5.1 Summit Pharmaceuticals Europe Srl Valsartan API Corporation Information
7.5.2 Summit Pharmaceuticals Europe Srl Valsartan API Product Portfolio
7.5.3 Summit Pharmaceuticals Europe Srl Valsartan API Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Summit Pharmaceuticals Europe Srl Main Business and Markets Served
7.5.5 Summit Pharmaceuticals Europe Srl Recent Developments/Updates
7.6 Octavius Pharma Pvt. Ltd
7.6.1 Octavius Pharma Pvt. Ltd Valsartan API Corporation Information
7.6.2 Octavius Pharma Pvt. Ltd Valsartan API Product Portfolio
7.6.3 Octavius Pharma Pvt. Ltd Valsartan API Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Octavius Pharma Pvt. Ltd Main Business and Markets Served
7.6.5 Octavius Pharma Pvt. Ltd Recent Developments/Updates
7.7 Synaptics Labs
7.7.1 Synaptics Labs Valsartan API Corporation Information
7.7.2 Synaptics Labs Valsartan API Product Portfolio
7.7.3 Synaptics Labs Valsartan API Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Synaptics Labs Main Business and Markets Served
7.7.5 Synaptics Labs Recent Developments/Updates
7.8 Ami Lifesciences Private Limited
7.8.1 Ami Lifesciences Private Limited Valsartan API Corporation Information
7.8.2 Ami Lifesciences Private Limited Valsartan API Product Portfolio
7.8.3 Ami Lifesciences Private Limited Valsartan API Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Ami Lifesciences Private Limited Main Business and Markets Served
7.7.5 Ami Lifesciences Private Limited Recent Developments/Updates
7.9 Zhuhai Rundu Pharmaceutical Co.,Ltd
7.9.1 Zhuhai Rundu Pharmaceutical Co.,Ltd Valsartan API Corporation Information
7.9.2 Zhuhai Rundu Pharmaceutical Co.,Ltd Valsartan API Product Portfolio
7.9.3 Zhuhai Rundu Pharmaceutical Co.,Ltd Valsartan API Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Zhuhai Rundu Pharmaceutical Co.,Ltd Main Business and Markets Served
7.9.5 Zhuhai Rundu Pharmaceutical Co.,Ltd Recent Developments/Updates
7.10 Zhejiang Tianyu Pharmaceutical
7.10.1 Zhejiang Tianyu Pharmaceutical Valsartan API Corporation Information
7.10.2 Zhejiang Tianyu Pharmaceutical Valsartan API Product Portfolio
7.10.3 Zhejiang Tianyu Pharmaceutical Valsartan API Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Zhejiang Tianyu Pharmaceutical Main Business and Markets Served
7.10.5 Zhejiang Tianyu Pharmaceutical Recent Developments/Updates
7.11 Menovo Pharmaceutical Co Ltd
7.11.1 Menovo Pharmaceutical Co Ltd Valsartan API Corporation Information
7.11.2 Menovo Pharmaceutical Co Ltd Valsartan API Product Portfolio
7.11.3 Menovo Pharmaceutical Co Ltd Valsartan API Production, Value, Price and Gross Margin (2018-2023)
7.11.4 Menovo Pharmaceutical Co Ltd Main Business and Markets Served
7.11.5 Menovo Pharmaceutical Co Ltd Recent Developments/Updates
7.12 Sun Pharma
7.12.1 Sun Pharma Valsartan API Corporation Information
7.12.2 Sun Pharma Valsartan API Product Portfolio
7.12.3 Sun Pharma Valsartan API Production, Value, Price and Gross Margin (2018-2023)
7.12.4 Sun Pharma Main Business and Markets Served
7.12.5 Sun Pharma Recent Developments/Updates
7.13 Mylan
7.13.1 Mylan Valsartan API Corporation Information
7.13.2 Mylan Valsartan API Product Portfolio
7.13.3 Mylan Valsartan API Production, Value, Price and Gross Margin (2018-2023)
7.13.4 Mylan Main Business and Markets Served
7.13.5 Mylan Recent Developments/Updates
7.14 Cadila Pharmaceuticals
7.14.1 Cadila Pharmaceuticals Valsartan API Corporation Information
7.14.2 Cadila Pharmaceuticals Valsartan API Product Portfolio
7.14.3 Cadila Pharmaceuticals Valsartan API Production, Value, Price and Gross Margin (2018-2023)
7.14.4 Cadila Pharmaceuticals Main Business and Markets Served
7.14.5 Cadila Pharmaceuticals Recent Developments/Updates
7.15 Mankind Pharma
7.15.1 Mankind Pharma Valsartan API Corporation Information
7.15.2 Mankind Pharma Valsartan API Product Portfolio
7.15.3 Mankind Pharma Valsartan API Production, Value, Price and Gross Margin (2018-2023)
7.15.4 Mankind Pharma Main Business and Markets Served
7.15.5 Mankind Pharma Recent Developments/Updates
7.16 Zhejiang Huahai Pharmaceutical
7.16.1 Zhejiang Huahai Pharmaceutical Valsartan API Corporation Information
7.16.2 Zhejiang Huahai Pharmaceutical Valsartan API Product Portfolio
7.16.3 Zhejiang Huahai Pharmaceutical Valsartan API Production, Value, Price and Gross Margin (2018-2023)
7.16.4 Zhejiang Huahai Pharmaceutical Main Business and Markets Served
7.16.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
7.17 Ipca Laboratories
7.17.1 Ipca Laboratories Valsartan API Corporation Information
7.17.2 Ipca Laboratories Valsartan API Product Portfolio
7.17.3 Ipca Laboratories Valsartan API Production, Value, Price and Gross Margin (2018-2023)
7.17.4 Ipca Laboratories Main Business and Markets Served
7.17.5 Ipca Laboratories Recent Developments/Updates
7.18 Zhejiang Hisun Pharmaceutical
7.18.1 Zhejiang Hisun Pharmaceutical Valsartan API Corporation Information
7.18.2 Zhejiang Hisun Pharmaceutical Valsartan API Product Portfolio
7.18.3 Zhejiang Hisun Pharmaceutical Valsartan API Production, Value, Price and Gross Margin (2018-2023)
7.18.4 Zhejiang Hisun Pharmaceutical Main Business and Markets Served
7.18.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
7.19 DEAFARMA
7.19.1 DEAFARMA Valsartan API Corporation Information
7.19.2 DEAFARMA Valsartan API Product Portfolio
7.19.3 DEAFARMA Valsartan API Production, Value, Price and Gross Margin (2018-2023)
7.19.4 DEAFARMA Main Business and Markets Served
7.19.5 DEAFARMA Recent Developments/Updates
7.20 CHEMO
7.20.1 CHEMO Valsartan API Corporation Information
7.20.2 CHEMO Valsartan API Product Portfolio
7.20.3 CHEMO Valsartan API Production, Value, Price and Gross Margin (2018-2023)
7.20.4 CHEMO Main Business and Markets Served
7.20.5 CHEMO Recent Developments/Updates
7.21 Laurus Labs
7.21.1 Laurus Labs Valsartan API Corporation Information
7.21.2 Laurus Labs Valsartan API Product Portfolio
7.21.3 Laurus Labs Valsartan API Production, Value, Price and Gross Margin (2018-2023)
7.21.4 Laurus Labs Main Business and Markets Served
7.21.5 Laurus Labs Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Valsartan API Industry Chain Analysis
8.2 Valsartan API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Valsartan API Production Mode & Process
8.4 Valsartan API Sales and Marketing
8.4.1 Valsartan API Sales Channels
8.4.2 Valsartan API Distributors
8.5 Valsartan API Customers
9 Valsartan API Market Dynamics
9.1 Valsartan API Industry Trends
9.2 Valsartan API Market Drivers
9.3 Valsartan API Market Challenges
9.4 Valsartan API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned: 

Biophore India Pharmaceuticals Pvt Ltd
Dr. Reddy's Laboratories
NEWEDGE Overseas
Suanfarma
Summit Pharmaceuticals Europe Srl
Octavius Pharma Pvt. Ltd
Synaptics Labs
Ami Lifesciences Private Limited
Zhuhai Rundu Pharmaceutical Co.,Ltd
Zhejiang Tianyu Pharmaceutical
Menovo Pharmaceutical Co Ltd
Sun Pharma
Mylan
Cadila Pharmaceuticals
Mankind Pharma
Zhejiang Huahai Pharmaceutical
Ipca Laboratories
Zhejiang Hisun Pharmaceutical
DEAFARMA
CHEMO
Laurus Labs

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/mrrpb5/global-valsartan-api-market-research-report-2023

Links
[1] /countries/global[2] /specialty-chemicals[3] /manufacturing-chemicals[4] /chemicals